These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23759142)

  • 21. Rett syndrome: of girls and mice--lessons for regression in autism.
    Glaze DG
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
    Young JI; Hong EP; Castle JC; Crespo-Barreto J; Bowman AB; Rose MF; Kang D; Richman R; Johnson JM; Berget S; Zoghbi HY
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17551-8. PubMed ID: 16251272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry.
    LaSalle JM; Goldstine J; Balmer D; Greco CM
    Hum Mol Genet; 2001 Aug; 10(17):1729-40. PubMed ID: 11532982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
    PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
    Balmer D; Arredondo J; Samaco RC; LaSalle JM
    Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
    Amir RE; Zoghbi HY
    Am J Med Genet; 2000; 97(2):147-52. PubMed ID: 11180222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.
    Nikitina T; Shi X; Ghosh RP; Horowitz-Scherer RA; Hansen JC; Woodcock CL
    Mol Cell Biol; 2007 Feb; 27(3):864-77. PubMed ID: 17101771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MeCP2: The Genetic Driver of Rett Syndrome Epigenetics.
    Good KV; Vincent JB; Ausió J
    Front Genet; 2021; 12():620859. PubMed ID: 33552148
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Olson CO; Pejhan S; Kroft D; Sheikholeslami K; Fuss D; Buist M; Ali Sher A; Del Bigio MR; Sztainberg Y; Siu VM; Ang LC; Sabourin-Felix M; Moss T; Rastegar M
    Front Genet; 2018; 9():635. PubMed ID: 30619462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders.
    Samaco RC; Nagarajan RP; Braunschweig D; LaSalle JM
    Hum Mol Genet; 2004 Mar; 13(6):629-39. PubMed ID: 14734626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
    Jin Z; Olaru A; Yang J; Sato F; Cheng Y; Kan T; Mori Y; Mantzur C; Paun B; Hamilton JP; Ito T; Wang S; David S; Agarwal R; Beer DG; Abraham JM; Meltzer SJ
    Clin Cancer Res; 2007 Nov; 13(21):6293-300. PubMed ID: 17975140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.
    Misawa K; Kanazawa T; Misawa Y; Imai A; Uehara T; Mochizuki D; Endo S; Takahashi G; Mineta H
    J Cancer Res Clin Oncol; 2013 May; 139(5):879-89. PubMed ID: 23420374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the methylation of CpG islands in the
    Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
    Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.
    Jiang Y; Matevossian A; Guo Y; Akbarian S
    Neuropharmacology; 2011 Jun; 60(7-8):1088-97. PubMed ID: 20869373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production.
    Abuhatzira L; Makedonski K; Kaufman Y; Razin A; Shemer R
    Epigenetics; 2007; 2(4):214-22. PubMed ID: 18075316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of MeCP2 function is associated with distinct gene expression changes in the striatum.
    Zhao YT; Goffin D; Johnson BS; Zhou Z
    Neurobiol Dis; 2013 Nov; 59():257-66. PubMed ID: 23948639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.